DNA Chip Research, Inc.

  • Market Cap: Small Cap
  • Industry: Medical/Nursing Services
  • ISIN: JP3548590003
JPY
1,092.00
2 (0.18%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Mar'24
Dec'23
Sep'23
Jun'23
Mar'23
Dec'22
Sep'22
Net Sales
219.05
106.62
97.37
67.42
160.24
78.35
59.31
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
219.05
106.62
97.37
67.42
160.24
78.35
59.31
Raw Material Cost
143.01
101.04
92.96
87.09
124.59
103.81
80.74
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
98.62
60.80
55.30
60.85
70.13
70.37
61.33
Other Expenses
0.00
2.01
1.39
1.50
0.63
2.10
1.50
Total Expenditure (Excl Depreciation)
241.63
181.99
162.11
162.95
201.02
195.17
157.07
Operating Profit (PBDIT) excl Other Income
-22.599999999999998
-75.4
-64.7
-95.5
-40.8
-116.8
-97.8
Other Income
-1.66
-0.97
0.00
0.02
-2.08
0.02
0.00
Operating Profit (PBDIT)
-13.33
-65.51
-54.89
-85.21
-34.51
-112.01
-95.42
Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Exceptional Items
-0.51
0.70
-0.34
-0.36
-3.24
7.65
0.00
Gross Profit (PBDT)
76.04
5.58
4.41
-19.68
35.65
-25.45
-21.43
Depreciation
10.91
10.82
9.85
10.26
8.35
4.79
2.34
Profit Before Tax
-9.84
-75.64
-65.08
-95.84
-46.10
-109.15
-97.76
Tax
0.47
0.47
0.47
0.47
0.63
0.24
0.24
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
-10.32
-76.11
-65.55
-96.31
-46.73
-109.39
-98.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
-10.32
-76.11
-65.55
-96.31
-46.73
-109.39
-98.00
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
-10.32
-76.11
-65.55
-96.31
-46.73
-109.39
-98.00
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
732.36
472.67
548.79
614.34
710.65
477.38
594.42
Earnings per share (EPS)
-1.6
-11.99
-10.32
-15.16
-7.72
-18.76
-16.91
Diluted Earnings per share
-1.6
-11.99
-10.32
-15.16
-7.72
-18.76
-16.91
Operating Profit Margin (Excl OI)
-10.31%
-70.68%
-66.49%
-141.64%
-25.45%
-149.09%
-164.83%
Gross Profit Margin
0.49%
-60.79%
-56.71%
-126.93%
-23.56%
-133.2%
-160.88%
PAT Margin
-4.71%
-71.38%
-67.32%
-142.85%
-29.16%
-139.61%
-165.23%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Mar 2024 is 36.70% vs -23.02% in Mar 2023

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Mar 2024 is 77.94% vs -223.54% in Mar 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Mar 2024 is 63.89% vs -231.17% in Mar 2023

stock-summary

Interest

No Interest in the last few periods

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Mar 2024 has improved from Mar 2023

Compare Quarterly Results Of DNA Chip Research, Inc. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(JPY)
Change(%)
Net Sales
219.05
702.66
-483.61
-68.83%
Other Operating Income
0.00
0.00
0.00
Total Operating income
219.05
702.66
-483.61
-68.83%
Raw Material Cost
143.01
499.86
-356.85
-71.39%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.00
4.31
-4.31
-100.00%
Selling and Distribution Expenses
98.62
222.42
-123.80
-55.66%
Other Expenses
0.00
-0.43
0.43
100.00%
Total Expenditure (Excl Depreciation)
241.63
722.29
-480.66
-66.55%
Operating Profit (PBDIT) excl Other Income
-22.58
-19.62
-2.96
-15.09%
Other Income
-1.66
-0.01
-1.65
-16,500.00%
Operating Profit (PBDIT)
-13.33
-19.53
6.20
31.75%
Interest
0.00
4.31
-4.31
-100.00%
Exceptional Items
-0.51
0.00
-0.51
Gross Profit (PBDT)
76.04
202.80
-126.76
-62.50%
Depreciation
10.91
0.11
10.80
9,818.18%
Profit Before Tax
-9.84
-23.95
14.11
58.91%
Tax
0.47
0.59
-0.12
-20.34%
Provisions and contingencies
0
0
0.00
Profit After Tax
-10.32
-24.54
14.22
57.95%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
-10.32
-24.54
14.22
57.95%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
-10.32
-24.54
14.22
57.95%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
732.36
1,778.52
-1,046.16
-58.82%
Earnings per share (EPS)
-1.60
-1.92
0.32
16.67%
Diluted Earnings per share
-1.60
-1.92
0.32
16.67%
Operating Profit Margin (Excl OI)
-10.31%
-2.79%
0.00
-7.52%
Gross Profit Margin
0.49%
-3.39%
0.00
3.88%
PAT Margin
-4.71%
-3.49%
0.00
-1.22%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 21.90 Million
in Mar 2024

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2024 is 105.44% vs 9.45% in Dec 2023

stock-summary

YoY Growth in quarter ended Mar 2024 is 36.70% vs -23.02% in Mar 2023

Quarterly - Consolidate Net Profit
Consolidate Net Profit -1.03 Million
in Mar 2024

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2024 is 86.47% vs -16.18% in Dec 2023

stock-summary

YoY Growth in quarter ended Mar 2024 is 77.94% vs -223.54% in Mar 2023

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) -1.17 Million
in Mar 2024

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2024 is 81.86% vs -17.49% in Dec 2023

stock-summary

YoY Growth in quarter ended Mar 2024 is 63.89% vs -231.17% in Mar 2023

Quarterly - Interest
Markets Mojo
No Interest in the last few periods
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) -10.31%
in Mar 2024

Figures in %
stock-summary

QoQ Growth in quarter ended Mar 2024 has improved from Dec 2023

stock-summary

YoY Growth in quarter ended Mar 2024 has improved from Mar 2023